Nabriva Therapeutics plc Contractual Obligation
Nabriva Therapeutics plc had Contractual Obligation of $46.31 million as of 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Notes › Commitment and Contingencies › Contractual Obligation, Fiscal Year Maturity
us-gaap:ContractualObligation · last filed 2023-05-22
- 2023-03-31: Contractual Obligation $46.31M.
- 2022-12-31: Contractual Obligation $46.00M.
- 2021-12-31: Contractual Obligation $65.68M.
- 2020-12-31: Contractual Obligation $58.91M.
| Period end | Contractual Obligation |
|---|---|
| 2023-03-31 | $46.31M 10-Q · filed 2023-05-22 |
| 2022-12-31 | $46.00M 10-K · filed 2023-04-17 |
| 2021-12-31 | $65.68M 10-K · filed 2022-03-29 |
| 2020-12-31 | $58.91M 10-K · filed 2021-03-11 |
| 2019-12-31 | $55.63M 10-K · filed 2020-03-12 |
| 2018-12-31 | $13.67M 10-K · filed 2019-03-12 |
| 2017-12-31 | $13.88M 10-K · filed 2018-03-16 |
| 2017-09-30 | $33.82M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $43.01M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $50.87M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $57.93M 10-Q · filed 2017-11-09 |
| 2015-12-31 | $40.97M 10-K · filed 2017-03-24 |